M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Newbury Pharmaceuticals secures approval for Macitentan in Denmark
Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has received marketing authorisation for Macitentan Newbury in Denmark.
This is the first approval in a Scandinavian registration process. Approvals in Sweden and Norway are expected...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search